Company & Sponsor Intelligence
Ain Shams University
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials5
Recruiting1
Completed4
Countries1
Therapeutic footprint
anxietyepilepsyother_neurologyparkinsons
Indexed studies
NCT05670509Intranasal vs Buccal vs Intramuscular Midazolam for the Home and Emergency Treatment of Acute Seizures
epilepsy · EgyptPHASE4
epilepsy · EgyptPHASE4
NCT06606899A Comparison Between Oral Melatonin With Nasal Sevoflurane Versus Oral Chloral Hydrate With Nasal Sevoflurane in Sedation of Children Undergoing Brain MRI
other_neurology · EgyptNA
other_neurology · EgyptNA
NCT06255873Effects of L-Carnitine on Gastric Emptying in Children With Drug Resistant Epilepsy on Ketogenic Diet
epilepsy · EgyptNA
epilepsy · EgyptNA
NCT07138391Chamomile Gummies and Pediatric Dental Anxiety
anxiety · EgyptPHASE2,PHASE3
anxiety · EgyptPHASE2,PHASE3
NCT04308135Differences Between Patients With Vascular Parkinsonism and Parkinson's Disease
parkinsons · EgyptCOMPLETED
parkinsons · EgyptCOMPLETED
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →